Mizuho Cuts Acadia Healthcare (NASDAQ:ACHC) Price Target to $37.00

Acadia Healthcare (NASDAQ:ACHC) had its target price reduced by Mizuho from $48.00 to $37.00 in a report published on Tuesday,Benzinga reports. Mizuho currently has a neutral rating on the stock.

A number of other research analysts also recently commented on ACHC. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price objective for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. Bank of America reduced their price target on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th. Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $43.00 to $35.00 in a report on Friday, February 28th. TD Cowen reduced their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Finally, StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $52.19.

Acadia Healthcare Trading Up 1.6 %

NASDAQ ACHC opened at $30.12 on Tuesday. The firm’s 50 day moving average price is $37.41 and its two-hundred day moving average price is $45.60. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare has a twelve month low of $27.61 and a twelve month high of $82.41. The stock has a market cap of $2.80 billion, a price-to-earnings ratio of 9.88, a PEG ratio of 1.46 and a beta of 1.38.

Institutional Trading of Acadia Healthcare

Institutional investors have recently made changes to their positions in the business. Lindbrook Capital LLC lifted its stake in Acadia Healthcare by 1,342.0% during the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after purchasing an additional 671 shares during the period. Blue Trust Inc. lifted its position in shares of Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after buying an additional 345 shares during the period. Nisa Investment Advisors LLC boosted its stake in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after buying an additional 301 shares in the last quarter. Signaturefd LLC grew its position in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after acquiring an additional 1,004 shares during the period. Finally, Fifth Third Bancorp raised its stake in Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after acquiring an additional 454 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.